关于PARK-2基因多态性及其与非霍奇金淋巴瘤临床病理参数和基因表达的关系的第一份报告
Gehan Abd-Elfatah Tawfeek1, Reham Ahmed Abdelaziz2
1Clinical Pathology Department, Faculty of Medicine, Menoufia University, Egypt.
Human immunology
|April 16, 2025
概括
帕金 (PARK2) 基因多态 (rs1801474,rs1801334) 是非霍奇金淋巴瘤 (NHL) 的重要危险因素. 这些遗传变异与不良预后指标和减少基因表达相关,影响患者的结果.
科学领域:
- 遗传学和分子生物学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 非霍奇金淋巴瘤 (NHL) 是一种异质的淋巴状恶性瘤群.
- 了解遗传风险因素对于早期检测和改善患者结果至关重要.
- 帕金 (PARK2) 基因多态性在NHL发育中的作用在很大程度上仍未被探索.
研究的目的:
- 调查帕金 (PARK2) 基因多态 (rs1801474,rs1801334) 与患非霍奇金淋巴瘤 (NHL) 的风险之间的关联.
- 探索这些多形态与NHL患者临床病理特征和基因表达的相关性.
主要方法:
- 一项涉及142名NHL患者和142名健康对照者的病例控制研究.
- 使用PCR-RFLP进行PARK-2基因多态的基因定型 (rs1801474,rs1801334).
- 通过qRT-PCR评估PARK-2mRNA的表达.
- 临床数据收集包括分期,预后指数和生存率.
主要成果:
- 帕金 (PARK2) 基因多态性 (rs1801474,rs1801334) 和A等位基因被确定为NHL的显著风险因素.
- 特定的基因型 (AA,GA) 与表现不佳的状态,晚期阶段和较高的LDH和β2微球蛋白水平有关.
- 这些多态性与治疗反应不佳,生存率降低和PARK-2基因表达率降低相关.
结论:
- 帕金 (PARK2) 基因多态 rs1801474 和 rs1801334 是NHL的重要危险因素.
- 这些遗传变异与不良的临床病理参数有关.
- 对PARK-2基因表达的下调可能是观察到的关联的基础.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
13.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.6K
Pleiotropy
38.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
38.1K
Genome-wide Association Studies-GWAS
12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.1K


